Category: Include on Menu
-
Collapsing Iran Talks and Surging Oil Prices Fuel Sharp Wall Street Sell-Off
U.S. stocks suffered their worst session since the onset of the Iran conflict on Thursday as the collapse of peace negotiations between Washington and Tehran sent crude oil prices surging and rattled investor confidence across virtually every corner of the market. What began as a cautiously lower open turned into a broad-based rout after President…
-
Neurocrine unveils first expert guidance for tardive dyskinesia care in long-term facilities
Neurocrine Biosciences (NASDAQ:NBIX) on Thursday announced new expert consensus recommendations aimed at improving the screening, diagnosis and treatment of tardive dyskinesia (TD) among older adults living in long-term care settings. The recommendations were developed through a multidisciplinary Delphi panel and presented at the Society for Post-Acute and Long-Term Care Medical Association (PALTmed) PALTC26 Annual Conference…
-
Firefly partners with U.S. Defense Department on PTSD and TBI evaluation
Firefly Neuroscience, Inc. (NASDAQ:AIFF) said it has entered into a partnership with the U.S. Department of Defense to support the evaluation and treatment of active-duty service members and veterans affected by Post-Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI). The small-cap company, which has a market capitalization of about $23.88 million, has seen its…
-
Henkel to acquire Olaplex in $1.4 billion takeover deal
German consumer goods group Henkel (TG:HEN) has agreed to purchase prestige haircare brand Olaplex (NASDAQ:OLPX) in a transaction valued at approximately $1.4 billion, the company announced Thursday. The acquisition will be completed through an offer of $2.06 per share for Olaplex stock. Henkel said the agreement received unanimous approval from Olaplex’s board and represents an…
-
Lumexa Imaging reports solid Q4 growth and maintains 2026 outlook
Lumexa Imaging (NASDAQ:LMRI) released preliminary, unaudited results for the fourth quarter and full year ended December 31, 2025, highlighting continued revenue growth and improving operating performance despite ongoing net losses. Fourth-quarter consolidated revenue increased 7.9% year over year to $267.7 million. System-wide revenue rose 10.6%, while same-center advanced imaging volumes grew 12.7% on a consolidated…
-
Lunai Bioworks to acquire CNS drug delivery platform and Alzheimer’s assets for $20M
Lunai Bioworks Inc. (NASDAQ:LNAI) said it has signed a binding agreement to purchase blood-brain barrier delivery technology and central nervous system Alzheimer’s drug assets from Clemann Group, SAS in a deal valued at $20 million. The acquisition value is more than double Lunai’s current market capitalization of approximately $9.71 million, with the company’s shares recently…
-
UBS maintains bullish outlook for silver amid supportive real asset environment
UBS reaffirmed its positive stance on silver, saying the macroeconomic environment for real assets remains supportive and could drive prices higher despite recent volatility in the precious metals market. A recent sell-off has pushed silver prices to roughly $60 per ounce, as investors sought liquidity during ongoing geopolitical tensions in the Middle East. The decline…
-
Designer Brands shares climb 6% after Q4 earnings and revenue beat expectations
Designer Brands Inc. (NYSE:DBI) reported fourth-quarter results on Thursday that exceeded Wall Street estimates, sending the footwear retailer’s shares up nearly 6% in pre-market trading despite cautious guidance for the coming year. For the quarter ended January 31, 2026, the company posted an adjusted loss of $0.31 per share, outperforming the analyst consensus forecast of…
-
Commercial Metals shares slip nearly 4% after earnings miss despite revenue growth
Commercial Metals Company (NYSE:CMC) reported fiscal second-quarter 2026 results on Thursday that fell short of profit expectations even though revenue came in above forecasts. The company’s shares dropped about 3.7% in pre-market trading following the release. For the quarter ended February 28, 2026, Commercial Metals posted adjusted earnings of $1.16 per diluted share, missing the…
-
Nouveau Monde Graphite secures $335 million debt backing for Matawinie mine development
Nouveau Monde Graphite Inc. (NYSE:NMG) reported its 2025 financial results and outlined progress toward a final investment decision for the Phase 2 development of its Matawinie Mine, according to a company statement. The Montreal-based graphite developer said it has obtained a $335 million senior secured project debt commitment from Export Development Canada and the Canada…